{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:36Z","timestamp":1794274176692,"version":"4.9.0"},"reference-count":52,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,10,20]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Epstein-Barr virus (EBV) in Hodgkin's lymphoma (HL) cells has been considered as a prognostic marker for this heterogeneous disease, but studies have yielded mixed findings, likely because of selected patient series and failure to acknowledge an effect of age on outcome. This study assessed survival after HL in a population-based cohort large enough to examine the joint effects of EBV with other factors including age, sex, and histologic subtype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Included were 922 patients with classical HL diagnosed between mid-1988 and 1997 in the Greater San Francisco Bay Area, with archived biopsy specimens assayed for EBV with immunohistochemistry and in situ hybridization. Vital status was followed through December 30, 2003 (median follow-up time, 97 months). Overall and disease-specific survival were analyzed with the Kaplan-Meier method and Cox proportional hazards regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In children less than 15 years old, EBV presence was suggestively associated (P = .07) with favorable survival. In adults aged 15 to 44 years, EBV did not affect HL outcome, although a protective effect was suggested. In older adults (45 to 96 years), EBV presence nearly doubled the risk of overall and HL-specific mortality but only for patients with nodular sclerosis (NS) histologic subtype (hazard ratio for death = 2.5; 95% CI, 1.5 to 4.3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In HL, EBV tumor cell presence is associated with better survival in young patients and poorer survival in older patients with NS, independent of other factors. Variation in outcome by age and histology could indicate biologically distinct disease entities. Evidence that EBV is a meaningful prognostic marker may have therapeutic relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2005.02.6310","type":"journal-article","created":{"date-parts":[[2005,9,26]],"date-time":"2005-09-26T20:44:00Z","timestamp":1127767440000},"page":"7604-7613","source":"Crossref","is-referenced-by-count":143,"title":["Epstein-Barr Virus As a Marker of Survival After Hodgkin's Lymphoma: A Population-Based Study"],"prefix":"10.1200","volume":"23","author":[{"given":"Theresa H.M.","family":"Keegan","sequence":"first","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally L.","family":"Glaser","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Clarke","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Gulley","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona E.","family":"Craig","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"DiGiuseppe","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald F.","family":"Dorfman","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa B.","family":"Mann","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont; Stanford University Medical Center, Stanford, CA; University of North Carolina, Chapel Hill, NC; University of Pittsburgh, Pittsburgh, PA; Hartford Hospital, Hartford, CT; and Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012240222032"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950200203"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb02653.x"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900401)65:7<1635::AID-CNCR2820650730>3.0.CO;2-M"},{"key":"R5","unstructured":"Ries LAG, Elsner MP, Kosary CL, et al: (eds): SEER Cancer Statistics Review, 1973-1999.  Bethesda, MD, National Cancer Institute, 2002"},{"key":"R6","unstructured":"Mueller N: Hodgkin's disease, in Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention (ed 2).  New York, NY, Oxford University Press, pp,1996 893-919"},{"key":"R7","unstructured":"Mueller N, Grufferman S: The epidemiology of Hodgkin's disease, in Mauch PM, Armitage JO, Diehl V, et al (eds): Hodgkin's Disease.  Philadelphia, Lippincott Williams & Wilkins, pp 61,1999-77"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401724"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(96)80018-7"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001623801"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90157-0"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690827"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010415)91:8<1579::AID-CNCR1169>3.0.CO;2-L"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<394::AID-IJC3>3.0.CO;2-K"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1080\/028418699431942"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.3.182"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/98.3.319"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg065"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1774"},{"key":"R20","unstructured":"Herling M, Rassidakis GZ, Medeiros LJ, et al: Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: Associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 9:2114,2003-2120,"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000071843.09960.BF"},{"key":"R22","unstructured":"Levy A, Diomin V, Gopas J, et al: Hodgkin's lymphoma in the Bedouin of southern Israel: Epidemiological and clinical features. Isr Med Assoc J 2:501,2000-503,"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009113386"},{"key":"R24","unstructured":"Morente MM, Piris MA, Abraira V, et al: Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 90:2429,1997-2936,"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.2.442"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008337100424"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03815.x"},{"key":"R28","unstructured":"Vassallo J, Metze K, Traina F, et al: Expression of Epstein-Barr virus in classical Hodgkin's lymphomas in Brazilian adult patients. Haematologica 86:1227,2001-1228,"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000037958"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500432"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0567"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011240019516"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010715)92:2<218::AID-CNCR1312>3.0.CO;2-6"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.776"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.3.162"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1309\/MMAU-0QYH-7BHA-W8C2"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.7.2477"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20787"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200408150-00012"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11459"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1186\/bcr672"},{"key":"R42","unstructured":"Surveillance Epidemiology and End Results (SEER) Program: SEER*Stat Database: Incidence\u2014SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001).  Bethesda, MD, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, November, 2003"},{"key":"R43","unstructured":"Rooney CM, Bollard C, Huls MH, et al: Immunotherapy for Hodgkin's disease. Ann Hematol 81:S39,2002-S42,  (suppl 2)"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04902.x"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401097"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1493.bloodjournal8641493"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934"},{"key":"R48","unstructured":"Rickinson AB, Kieff E: Epstein-Barr virus, in Fields BN, Knipe DM, Howley PM, et al (eds): Field's Virology (ed 3).  Philadelphia, PA, Lippincott-Raven Publishers, pp,1996 2397-2446"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.7.2918.bloodjournal8772918"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<299::AID-PATH856>3.0.CO;2-8"},{"key":"R51","doi-asserted-by":"crossref","unstructured":"Seymour JF, Talpaz M, Hagemeister FB, et al: Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. Am J Med 102:21,1997-28,","DOI":"10.1016\/S0002-9343(96)00352-X"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109097719"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.02.6310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T16:52:00Z","timestamp":1653497520000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.02.6310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,20]]},"references-count":52,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2005,10,20]]}},"alternative-id":["10.1200\/JCO.2005.02.6310"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.02.6310","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,20]]}}}